About: Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1998 (uk) im März 1998 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57419117-14617CBF-3B82-4A99-BA66-58C03840C751
publication date	1998-03-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q57419117-06D77144-6FEF-4A13-A989-533288C04060 wds:Q57419117-09DEF153-837D-4C60-814F-647AA9971370 wds:Q57419117-1ABEB3F8-FA4C-47FD-9226-2E1DAB606F68 wds:Q57419117-1B4152BA-85DF-4DD2-B333-A8E4D0E627B3 wds:Q57419117-1C9CBA14-A9CA-40E9-B58A-B95DFB8FF452 wds:Q57419117-25B4BE62-0981-46E3-9C5F-F5501933B32D wds:Q57419117-292555DF-F732-4BF1-B611-8B3B83676A14 wds:Q57419117-392B52C8-704C-440A-91A1-4728B5A23833 wds:Q57419117-3F968CCF-5E54-4B50-8269-7DD02ECA2D20 wds:Q57419117-5306E1D9-09CE-40AD-BBEC-2327DFE3FC50 wds:Q57419117-598EB1E2-F734-4EDC-B219-6DB23241D749 wds:Q57419117-5F7FA8CE-08F4-491F-A67D-A12DF5DA291A wds:Q57419117-690EC13A-B420-4483-9A4E-BAB29422294E wds:Q57419117-71A3273B-2696-40D4-AAEA-00405F17FEC8 wds:Q57419117-8D7B744A-F883-453B-A7BA-E97541B5E6DB wds:Q57419117-909D97C5-43EA-4BE3-8A0E-C80093D670C4 wds:Q57419117-92F3CAF0-EC1F-4768-B20A-4DCEF6D17D94 wds:Q57419117-9C74E2C2-A477-4020-9E69-ED83DED9752F wds:Q57419117-9F03AC02-B3A2-48DA-8822-B8FE5663FB6F wds:Q57419117-A933E925-9DCD-4102-8717-EAD762CD3FC8 wds:Q57419117-BF219360-432C-4060-92A6-5F8A070640B6 wds:Q57419117-C3A6E617-61D7-40DE-A372-0066E3525854 wds:Q57419117-D7B4136C-C00D-435F-BF46-A1E3A2ABBF7E wds:Q57419117-DD16DD1A-72EF-4AC5-A350-261B68059464 wds:Q57419117-DD69BB96-239F-400B-932A-E8D412364644 wds:Q57419117-DE5EE83F-D4CE-4C05-B4BB-52B803988F52 wds:Q57419117-FC066ACE-79B8-4049-857E-C27ED128FFA0
cites work	Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease Brain Cytochrome Oxidase in Alzheimer's Disease Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Dementia of the Alzheimer Type Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Pupil dilation to tropicamide is not specific for Alzheimer disease. A potential noninvasive neurobiological test for Alzheimer's disease. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease. Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease. Cytochrome oxidase deficiency in Alzheimer's disease Platelet membrane abnormality in Alzheimer's disease Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 years. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease CSF somatostatin-like immunoreactivity in dementia Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. Neuronal thread protein over-expression in brains with Alzheimer's disease lesions. CSF neurotransmitter markers in Alzheimer's disease Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease Pathologic Changes in Olfactory Neurons in Alzheimer's Diseasea
rdfs:label	Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI) (en) Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A (nl)
skos:prefLabel	Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI) (en) Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A (nl)
name	Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI) (en) Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A (nl)
title	wds:Q57419117-1455ED98-35CE-418E-8A26-B88269201F05
title	Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI) (en)
page(s)	wds:Q57419117-62537972-6048-4F42-B35E-7A53BD3906F6
page(s)	109-116
instance of	wds:Q57419117-68397C90-F087-41B6-8693-A96955DC1D4E
instance of	scholarly article
published in	wds:Q57419117-1D014B42-46AB-4694-A97B-7A219EFECFE7
published in	Neurobiology of Aging
issue	wds:Q57419117-F43B0717-0DF9-483B-8379-EBF71F9F4E70
volume	wds:Q57419117-043EEAA4-04A0-4C20-B605-F39027DA87E7
issue	2
volume	19
DOI	wds:Q57419117-76096C76-E8CF-43EE-A59E-716537F62B9B
DOI	http://dx.doi.org/10.1016/S0197-4580(98)00022-0
DOI	10.1016/S0197-4580(98)00022-0
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57419117
is cites work of	Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease Accumulation of amyloid-beta protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor. Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Update on Alzheimer's disease. Promising advances in detection and treatment Anti-inflammatory drugs: a hope for Alzheimer's disease? Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid 3-Nitrotyrosine immunoreactivity in olfactory receptor neurons of patients with Alzheimer's disease: implications for impaired odor sensitivity Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature Alzheimer's disease Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Inflammation markers in relation to cognition in a healthy aging population. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment. Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software